AMC Health Appoints Sol Babani and Symbiosis Advisors as Strategic Advisor to Its Decentralized Clinical Trial Service Line
RIO
-0.3300
The Fort Worth Press - AMC Health Appoints Sol Babani and Symbiosis Advisors as Strategic Advisor to Its Decentralized Clinical Trial Service Line
USD
-
AED 3.672497
AFN 63.999956
ALL 80.712093
AMD 364.394871
ANG 1.790365
AOA 917.999929
ARS 1524.772602
AUD 1.42573
AWG 1.8
AZN 1.69968
BAM 1.717716
BBD 2.016134
BDT 123.177046
BGN 1.683441
BHD 0.377383
BIF 3014.939006
BMD 1
BND 1.278905
BOB 12.267697
BRL 5.184798
BSD 1.000953
BTN 95.858456
BWP 13.630595
BYN 3.024376
BYR 19600
BZD 2.013235
CAD 1.41578
CDF 2339.99971
CHF 0.831235
CLF 0.024356
CLP 961.698985
CNY 6.71325
CNH 6.71548
COP 3308.17
CRC 455.108332
CUC 1
CUP 24.025823
CVE 96.778865
CZK 21.451397
DJF 178.251648
DKK 6.57256
DOP 59.527678
DZD 133.813998
EGP 51.954902
ERN 15
ETB 162.38462
EUR 0.87924
FJD 2.237198
FKP 0.754816
GBP 0.753965
GEL 2.614961
GGP 0.754816
GHS 11.626559
GIP 0.754816
GMD 73.501114
GNF 8803.600834
GTQ 7.644576
GYD 209.441419
HKD 7.84449
HNL 26.866497
HRK 6.621696
HTG 131.00126
HUF 323.085988
IDR 17985
ILS 3.07055
IMP 0.754816
INR 95.977499
IQD 1311.329993
IRR 1374837.488724
ISK 120.449817
JEP 0.754816
JMD 158.367842
JOD 0.709027
JPY 156.891497
KES 129.704398
KGS 87.4482
KHR 4070.73506
KMF 432.999822
KPW 900.000318
KRW 1361.569759
KWD 0.30879
KYD 0.834171
KZT 443.156186
LAK 22452.716678
LBP 89639.254709
LKR 330.532926
LRD 172.178625
LSL 16.331596
LTL 2.95274
LVL 0.60489
LYD 6.399881
MAD 9.60592
MDL 17.768078
MGA 4419.404276
MKD 54.074585
MMK 2099.83552
MNT 3596.071123
MOP 8.087369
MRU 40.269447
MUR 47.470073
MVR 15.449874
MWK 1735.705221
MXN 17.81039
MYR 4.085604
MZN 63.909888
NAD 16.332887
NGN 1328.159801
NIO 36.833901
NOK 9.516024
NPR 153.367644
NZD 1.766985
OMR 0.384499
PAB 1.000307
PEN 3.398193
PGK 4.459726
PHP 62.49098
PKR 277.376198
PLN 3.849655
PYG 5900.150622
QAR 3.648779
RON 4.641401
RSD 103.327985
RUB 84.556345
RWF 1479.428955
SAR 3.756013
SBD 8.000512
SCR 13.903085
SDG 601.497816
SEK 9.957089
SGD 1.27858
SHP 0.755002
SLE 24.6501
SLL 20969.491881
SOS 572.098558
SRD 37.667502
STD 20697.981008
STN 21.503489
SVC 8.758887
SYP 13002.000254
SZL 16.327731
THB 33.594025
TJS 9.234445
TMT 3.51
TND 2.963376
TOP 2.40776
TRY 48.982745
TTD 6.80881
TWD 31.819503
TZS 2649.997998
UAH 44.823667
UGX 3920.604251
UYU 40.102584
UZS 11846.95307
VES 852.431449
VND 25971
VUV 117.801098
WST 2.745718
XAF 576.743816
XAG 0.016367
XAU 0.00024137157
XCD 2.70255
XCG 1.804034
XDR 0.707052
XOF 576.743816
XPF 104.742206
YER 236.649729
ZAR 16.44793
ZMK 9001.219283
ZMW 19.513758
ZWL 321.999592
SSP 5712.591895
MXV 2.016981
- Eala blasts into Asian Games quarters in just 55 minutes
- Ireland 'raised awareness worldwide' in Israel game: Hallgrimsson
- Taiwan gender-row boxer Lin Yu-ting guarantees Asian Games medal
- Colombian police capture wife, daughter of Ecuador drug lord
- Comedian on trial for allegedly insulting Erdogan in standup show
- More Asian Games woes as bus takes Pakistan team to wrong venue
- More Asian Games transport woes as bus takes Pakistan to wrong venue
- Radio frequencies vital to Earth observation must be protected: UN
- Death toll in South Africa bar shooting rises to 18
- Comedian on trial for insulting Erdogan in standup show
AMC Health Appoints Sol Babani and Symbiosis Advisors as Strategic Advisor to Its Decentralized Clinical Trial Service Line
Industry veteran brings deep CRO and biopharma expertise from ICON, PRA Health Sciences, and Covance to accelerate growth and operationalization of AMC Health's DCT platform
NEW YORK CITY, NY / ACCESS Newswire / May 5, 2026 / AMC Health today announced the appointment of Sol Babani, Founder and CEO of Symbiosis Advisors, as Strategic Advisor to its newly established Decentralized Clinical Trial (DCT) service line. Babani will work closely with CEO Nesim Bildirici and Keith Tode, Executive Vice President of Decentralized Clinical Trials, to grow and operationalize AMC Health's DCT platform as it expands its modular operating partner offering to biopharmaceutical sponsors, medical device companies, and CROs.
"As we move into active commercialization of our DCT service line, Sol's depth across the CRO and sponsor landscape is exactly the strategic muscle we need. He's not just advising, he's helping us build the commercial engine."
- Nesim Bildirici, Chief Executive Officer, AMC Health
ABOUT SOL BABANI & SYMBIOSIS ADVISORS
Sol Babani is the Founder of Symbiosis Advisors, a strategic advisory firm serving start-up and mid-market healthcare and life sciences companies. Symbiosis specializes in positioning organizations for growth, preparing them for the scrutiny of transactions, and building strategic partnerships and alliances - embedding directly within client leadership teams to align expertise with vision.
Babani brings decades of senior CRO and biopharma industry experience, having served as Senior Vice President at ICON Biotech, Senior Vice President of Drug Development at PRA Health Sciences, and Vice President of Biopharma Solutions at Covance. His career spans pharma, biotech, and medical device, giving AMC Health access to one of the most experienced commercial and operational minds in the clinical research industry.
"What caught my attention about AMC Health is how few companies in this space have both the clinical infrastructure and the operational maturity to serve as a true operating partner. That combination is rare, and it's exactly what the sponsor and CRO market is looking for right now."
- Sol Babani, Founder, Symbiosis Advisors & Strategic Advisor, AMC Health DCT
A STRATEGIC PARTNERSHIP BUILT FOR GROWTH
The appointment of Babani and Symbiosis Advisors reflects AMC Health's commitment to building its DCT service line with the commercial rigor and strategic infrastructure required to compete at the highest level of the clinical research market. With Babani's network and expertise in CRO and sponsor partnerships, AMC Health is positioned to accelerate the adoption of its modular DCT operating model across the life sciences industry.
ABOUT AMC HEALTH
AMC Health is a remote patient monitoring and decentralized clinical trial services company with a proven track record supporting the U.S. Department of Veterans Affairs. Through its DCT Platform, AMC Health delivers modular operating partner services to biopharmaceutical sponsors, medical device companies, and CROs across fully remote and hybrid clinical study designs. For more information, visit www.amchealth.com.
ABOUT SYMBIOSIS ADVISORS
Symbiosis Advisors is a strategic advisory firm helping start-up and mid-market healthcare and life sciences companies position themselves for success, prepare for transactions, and build top-tier strategic partnerships and alliances. Symbiosis works side by side with client leadership teams, embedding expertise directly within the organization to build stronger, more valuable companies. For more information, visit www.symbiosisadvisors.com.
Contact Information
Gary Feiner
Director of Marketing
[email protected]
(877) 262-2240
SOURCE: AMC Health
View the original press release on ACCESS Newswire
T.M.Dan--TFWP
